跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-SERTRALINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-SERTRALINE
Authorized
STANDARD
PRIVA-SERTRALINE
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d9a1f57bba3a9b58
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
d9a1f57bba3a9b58
Drug Approval Canada Name
PRIVA-SERTRALINE
Product Name
PRIVA-SERTRALINE
Status
Cancelled Post Market
Status Date
2023-04-01
Original Market Date
2016-11-23
Din
02445360
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB06 SERTRALINE
Atc Name
n 06 ab 06
Aig Number
0123417001
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
SERTRALINE (SERTRALINE HYDROCHLORIDE)
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d9a1f57bba3a9b58
Type
Standard
Back to Health Canada Approvals